Evidence map›Paper›PMID 41353462›Full record

ArticleScientific reports2025

A novel two-stage deep learning approach for lung cancer using enhanced ResNet50 segmentation and LungSwarmNet classification.

Kalaipriya Omprakash, Dhandapani Samiappan

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kalaipriya OmprakashECE Department, Anna University, Chennai, India. okalaipriya@gmail.com.
Dhandapani SamiappanSaveetha Engineering College, Chennai, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the leading killers globally now is lung cancer. It ranks high among the dangerous malignant tumors that people may have. It is the leading cause of cancer-related fatalities in both men and women globally, and its mortality rate is higher than that of any other malignant tumor. Medical image segmentation has seen the successful use of many deep learning framework-based techniques in recent years. The use of computer tomography (CT) has increased in the detection of lung cancer, a significant malignancy. Patients with lung cancer have a better chance of surviving if the disease is detected early. Early diagnosis allows professionals to deliver appropriate therapy within a specific period, which in turn reduces the fatality rate. The healthcare industry benefits greatly from the advanced services deep learning models offer. In this study, we present a deep neural network architecture named as lung swarm net that combines DenseNet201 with PSO to classify lung cancer from CT scans of the lung. We used ResNet50 for the segmentation procedure and DenseNet-201 with Particle Swarm Optimization (PSO) for the classification in order to identify lung cancer. According to the experimental data, the suggested model outperforms other current models in terms of accuracy.

Indexed as

Deep LearningImage Processing, Computer-AssistedLung NeoplasmsAlgorithmsFemaleHumansMaleNeural Networks, ComputerTomography, X-Ray ComputedClassificationCNNDenseNet-201Lung cancerPSOResNet50Segmentation

Identifiers

PMID41353462
PMCPMC12796376

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.